Gastroesophageal Reflux Disease (GERD) Secondary to Asthma / Reactive Airway Disease

Yes. Under 38 CFR § 3.310(a), any disability proximately caused or chronically worsened by a service-connected condition is itself service-connected. Gastroesophageal Reflux Disease (GERD) is a documented secondary pairing for Asthma / Reactive Airway Disease with strong medical evidence. A nexus letter from a qualified physician linking the two conditions is the most reliable way to establish this connection.

The gold standard is a private nexus opinion stating — to at least a 50% probability ("at least as likely as not") — that the secondary condition was caused or aggravated by the primary service-connected condition. Peer-reviewed medical literature supporting the physiological mechanism strengthens the nexus. Treatment records documenting the onset or worsening of the secondary condition in temporal relation to the primary are supporting evidence.

The VA rates Gastroesophageal Reflux Disease (GERD) separately under its own 38 CFR Part 4 diagnostic code, then combines it with Asthma / Reactive Airway Disease and all other service-connected ratings using the combined ratings formula under § 4.25. The formula applies the whole-person concept: a 50% combined existing rating plus a new 30% rating yields 65% (rounded to 70%), not 80%.

38 CFR § 3.310(a) states: "Disability which is proximately due to or the result of a service-connected disease or injury shall be service connected." The aggravation variant under § 3.310(b) applies where the primary condition permanently worsens a pre-existing disability beyond its natural progression. Both standards require a showing of nexus — a medical or scientific link between the primary condition and the secondary.

The medical evidence supporting Gastroesophageal Reflux Disease (GERD) as secondary to Asthma / Reactive Airway Disease is rated strong. Asthma and GERD have a bidirectional, well-established comorbid relationship with multiple reinforcing mechanisms. Acid reflux exacerbates asthma through vagally-mediated bronchospasm triggered by esophageal acid exposure (esophago-bronchial reflex), microaspiration of acid droplets causing direct airway mucosal inflammation, and activation of esophageal afferents that enhance bronchial reactivity. Conversely, asthma promotes GERD: (1) hyperinflation from air trapping increases intraabdominal-to-intrathoracic pressure gradient, reducing lower esophageal sphincter effectiveness; (2) bronchodilators used for asthma treatment (theophylline, beta-2 agonists) relax the lower esophageal sphincter; (3) oral corticosteroids increase gastric acid secretion. Studies document GERD in 34–89% of asthmatic patients. Clinical trials show that GERD treatment improves nocturnal asthma control, confirming the causal pathway from GERD to asthma worsening and vice versa.

The VA will not solicit nexus evidence on your behalf for secondary claims. In practice, a written nexus opinion from a private physician or independent medical examiner is essential — the VA's Compensation & Pension (C&P) examiner is not required to produce a favorable nexus opinion, and the VA has discretion to weigh competing opinions. Submitting a private nexus letter at the time of filing is the most reliable strategy.